ACADIA Pharmaceuticals's total assets for Q4 2025 were $1.56B, an increase of 17.54% from the previous quarter. ACAD total liabilities were $336.81M for the fiscal quarter, a -18.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.